CD19 Monoclonal Antibody (eBio1D3 (1D3)), PerCP-Cyanine5.5 (45-0193-82)
CD19 Monoclonal Antibody (SJ25-C1), PE-Alexa Fluor™ 610 (MHCD1922)
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
Recreation of an antigen-driven germinal center in vitro by providing B cells with phagocytic antigen | Communications Biology
Lymphoma Development in Pten L/L Ship L/L Cd19 Cre Mice Occurs in a... | Download Scientific Diagram
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response
iKP CAR construction and expression. (A) Schematic diagram of the... | Download Scientific Diagram
ExCellerate B Cell Media, Xeno-Free (CCM031): R&D Systems®
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes - ScienceDirect
Normal B-cell ranges in infants: A systematic review and meta-analysis - ScienceDirect
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
JCM | Free Full-Text | Development of CAR T Cell Therapy in Children—A Comprehensive Overview
CAR T Cell Immunotherapy Beyond Haematological Malignancy
Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab | Haematologica
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage | Leukemia
Elevated peripheral blood B lymphocytes and CD3+CD4‑CD8‑ T lymphocytes in patients with non‑small cell lung cancer: A preliminary study on peripheral immune profile
Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
CD19 Monoclonal Antibody (eBio1D3 (1D3)), PerCP-Cyanine5.5 (45-0193-82)
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis - Shujun Guo, Qingqing Chen, Xiaoli Liang, Mimi Mu, Jing He, Qiang
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ...
The defect of B cell development in CD19-Cre + PDK1 flox/flox mice is... | Download Scientific Diagram
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
Characteristics of iKP-19-CAR-T cells and CD19-CAR-T cells.... | Download Scientific Diagram
